CARLSBAD, CA June
12, 2012, International Stem Cell Corporation (OTCBB: ISCO)
www.internationalstemcell.com has announced new sales and marketing initiatives for its Lifeline
Skin Care products (
www.lifelineskincare.com). These efforts are
designed to enable Lifeline to robustly, strategically and profitably grow the
business.
Consumer
Advertising
During June and
July, new integrated advertising campaigns will be
launched in three marketing channels—online, in newspapers and magazines, and
through direct mail. The campaigns will
feature Lifeline’s innovative stem cell technology and proof of the brand’s
potential: younger looking skin. Although the ads will eventually be national
in reach, the first few months will be devoted to optimizing the creative approach,
targeting, frequency, timing, positioning, offer and ROI.
Key
Opinion Leader and Peer Group Influencer
Elizabeth
K. Hale, MD., one of the nation's top dermatologists, is now endorsing Lifeline
Skin Care to both consumer and trade audiences.
Dr. Hale is an Associate Clinical Professor of Dermatology at New York
University, a private practitioner and a guest of the Doctor Oz show, the Today
Show and Good Morning America. During
the week of June 4 she met with beauty editors for Prevention, Health, Town and
Country, Allure,
FoxNews.com and InStyle, to
present Lifeline Skin Care and its unique technology. The endorsement of a leading dermatologist
should not only enhance the credibility of the brand but increase its
visibility.
Strategic
Partners
Email
campaigns through strategic partners have been very successful at marketing
Lifeline products. To expand that
effort, several new key opinion leaders have now agreed to endorse Lifeline
Skin Care to their social networks, including Mrs. Jeri Thompson, a conservative
spokesperson, radio and TV guest and advocate for non-embryonic stem cell
research; and authors, experts and media personalities in the areas of women's
health, yoga, cosmetic dentistry, and retirement planning. Many of these partners plan to market
Lifeline through their social network (email marketing, blogs, Facebook, etc.)
as well as through personal and radio appearances. Most of these campaigns will launch during
the third quarter.
Professional
Channels
During
the week of June 12, Lifeline is launching two campaigns directed to 27,000
cosmetic dermatologists and day spas. These campaigns are focused on providing
information to skin care professionals, including dermatologists and plastic
surgeons, to understand and embrace the significance and value of stem cell
extracts for skin rejuvenation.
Donna Queen,
newly appointed President and CEO of Lifeline Skin Care said, “There is an
enormous opportunity for us in skincare and we’re now prepared to commit the
people, energy and resources. We intend
to take the leadership role and intend to make Lifeline own the stem cell
skincare category. Effective
immediately, we are accelerating and expanding our marketing and sales efforts
to increase awareness and drive sales.
“Increasing
awareness of Lifeline’s unique technology will enable us to stand apart and
ahead in the anti-aging category. Stem cell skin care is still in a nascent
phase, it’s time for us to seize the opportunity,” continued Ms. Queen.
About International
Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic
applications of human parthenogenetic stem cells (hpSCs) and the development
and commercialization of cell-based research and cosmetic products. ISCO's core
technology, parthenogenesis, results in the creation of pluripotent human stem
cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated
with the use or destruction of viable human embryos. ISCO scientists have
created the first parthenogenic, homozygous stem cell line that can be a source
of therapeutic cells for hundreds of millions of individuals of differing
genders, ages and racial background with minimal immune rejection after
transplantation. hpSCs offer the potential to create the first true stem cell
bank, UniStemCell™. ISCO also produces and markets specialized cells and growth
media for therapeutic research worldwide through its subsidiary Lifeline Cell
Technology (
www.lifelinecelltech.com), and stem cell-based skin care products
through its subsidiary Lifeline Skin Care (
www.lifelineskincare.com). More
information is available at
www.internationalstemcell.com
or follow us on Twitter @intlstemcell.
Forward-looking
Statements
Statements pertaining to anticipated developments, the
potential benefits of sales and marketing initiatives, and other opportunities
for the company and its subsidiaries, along with other statements about the
future expectations, beliefs, goals, plans, or prospects expressed by management
constitute forward-looking statements. Any statements that are not historical
fact (including, but not limited to statements that contain words such as
"will," "believes," "plans,"
"anticipates," "expects," "estimates,") should
also be considered to be forward-looking statements. Forward-looking statements
involve risks and uncertainties, including, without limitation, competitive
conditions and developments, the need and ability to obtain future capital,
application of capital resources among competing uses, and maintenance of
intellectual property rights. Actual results may differ materially from the
results anticipated in these forward-looking statements and as such should be
evaluated together with the many uncertainties that affect the company's business,
particularly those mentioned in the cautionary statements found in the
company's Securities and Exchange Commission filings. The company disclaims any
intent or obligation to update forward-looking statements.
Contacts:
International Stem Cell Corporation
Dr. Simon Craw, Executive Vice President Business Development
Phone: 760-940-6383
Investor Relations:
MZ Group
Mark McPartland
Phone: 212-301-7130
Email: markmcp@mzgroup.us
